Early research (Phase 1)Study completedNCT02155582What this trial is testingCopanlisib Pharmacodynamic StudyWho this might be right forNon Hodgkin Lymphoma Bayer 63
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Study completedNCT00045500What this trial is testingUCN-01 and Prednisone in Treating Patients With Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Early research (Phase 1)Study completedNCT01158274What this trial is testingRO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00458731What this trial is testingBevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+59 more National Cancer Institute (NCI) 57
Not applicableStudy completedNCT00445731What this trial is testingA Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forCancer University of Minnesota 115
Early research (Phase 1)Active Not RecruitingNCT03212404What this trial is testingPhase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersWho this might be right forLung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more Checkpoint Therapeutics, Inc. 272
Testing effectiveness (Phase 2)Study completedNCT00003425What this trial is testingPhase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectWho this might be right forBreast CancerLeukemiaLymphoma+4 more University of Kentucky 25
Early research (Phase 1)Study completedNCT00652626What this trial is testingPharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal FunctionWho this might be right forMDSAMLSolid Tumors+3 more Celgene 31
Early research (Phase 1)Study completedNCT00004258What this trial is testingEMD 121974 in Treating Patients With Locally Advanced or Metastatic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Indiana University 40
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Study completedNCT00003368What this trial is testingIrinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the PelvisWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04284774What this trial is testingTipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment TrialWho this might be right forMalignant Solid NeoplasmRecurrent Adrenal Gland PheochromocytomaRecurrent Ectomesenchymoma+38 more National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00002543What this trial is testingGallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsLymphomaNeuroblastoma+2 more Medical College of Wisconsin 3
Testing effectiveness (Phase 2)Study completedNCT00237627What this trial is testingDoxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast CancerWho this might be right forBreast CancerLeukemiaLymphoma+3 more UNC Lineberger Comprehensive Cancer Center 107
Early research (Phase 1)Study completedNCT00470405What this trial is testingPemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or LymphomaWho this might be right forLymphomaSolid Tumor Vanderbilt-Ingram Cancer Center 25
Early research (Phase 1)Study completedNCT00572637What this trial is testingPhase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's LymphomasWho this might be right forSolid TumorsLymphoma, Non-Hodgkin Ethical Oncology Science 55
Testing effectiveness (Phase 2)Study completedNCT00066248What this trial is testingCyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer TreatmentWho this might be right forBrain TumorCentral Nervous System TumorsCachexia+5 more University of South Florida 70
Testing effectiveness (Phase 2)Study completedNCT00070421What this trial is testingStudy of @neWorld: A Virtual Community for Children With CancerWho this might be right forLeukemiaLymphomaPsychosocial Effects of Cancer and Its Treatment+1 more Leap of Faith Technologies